Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
denileukin diftitox interleukin-2 receptor subunit alpha biotech NA drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
leukemia[MeSHID:D007938]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 4.39 approved,investigational binder
denileukin diftitox interleukin-2 receptor subunit alpha biotech NA drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
leukemia[MeSHID:D007938]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational binder
denileukin diftitox interleukin-2 receptor subunit beta biotech NA drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
leukemia[MeSHID:D007938]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational agonist
denileukin diftitox interleukin-2 receptor subunit beta biotech NA drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
leukemia[MeSHID:D007938]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 15.91 approved,investigational agonist
denileukin diftitox cytokine receptor common subunit gamma biotech NA drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
leukemia[MeSHID:D007938]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational unknown
denileukin diftitox cytokine receptor common subunit gamma biotech NA drugbank , DGIDB Lymphoma
T-Cell
Cutaneous[MeSHID:D016410]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
leukemia[MeSHID:D007938]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 12.73 approved,investigational unknown
click here to return to the previous page